Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03744507 · ClinicalTrials.gov registry record
Bone Mineral Density in Women With Uterine Fibroids or Endometriosis
A clinical trial, sponsored by Myovant Sciences.
- Completed
- Registry status
- 660
- Enrollment target
NCT03744507: Completed study, sponsored by Myovant Sciences.
NCT03744507 is a clinical trial that has completed, run by Myovant Sciences. The registered enrollment target is 660 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03744507 has completed, sponsored by Myovant Sciences.
- COMPLETED
- Registry status
- 660 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the longitudinal bone mineral density (BMD) in premenopausal women with uterine fibroids or endometriosis.
Primary Outcome
Assessed by dual-energy X-ray absorptiometry (DXA) scan.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 660 participants |
| Start Date | 2018-08-03 |
| Est. Completion | 2020-07-31 |
What the finished NCT03744507 record still lists
NCT03744507 is an observational study that tracks outcomes without assigning an intervention. The registered 660 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03744507 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03744507 about?
NCT03744507 is a clinical study titled "Bone Mineral Density in Women With Uterine Fibroids or Endometriosis". The purpose of this study is to characterize the longitudinal bone mineral density (BMD) in premenopausal women with uterine fibroids or endometriosis.
What is the current status of trial NCT03744507?
This trial is currently completed. The enrollment target is 660 participants. The study started on 2018-08-03. Estimated completion is 2020-07-31.
Who is sponsoring clinical trial NCT03744507?
This trial is sponsored by Myovant Sciences, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01185132 · 660 participants · Phase 3
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
- NCT03346694 · 660 participants · NA
Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
- NCT05407636 · 660 participants · Phase 3
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
- NCT05470205 · 660 participants · Phase 3
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI